| Category | Name | IntersectionWithQuery | PValue | GenesInTerm | GenesInQuery | GenesInTermInQuery | ID |
|---|---|---|---|---|---|---|---|
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-OH group of donors, NAD or NADP as acceptor | IMPDH2 LDHAL6B PTGR2 HMGCR LDHA LDHB LDHC ADH1B ADH1C ADH4 ADH6 CRYL1 PTGR1 | 2.30e-12 | 127 | 131 | 13 | GO:0016616 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on CH-OH group of donors | IMPDH2 LDHAL6B PTGR2 HMGCR LDHA LDHB LDHC ADH1B ADH1C ADH4 ADH6 CRYL1 PTGR1 | 6.70e-12 | 138 | 131 | 13 | GO:0016614 |
| GeneOntologyMolecularFunction | transporter activity | SLC38A9 SLC26A2 FLVCR1 TOMM20 ABCC9 SLC30A2 AQP3 ATP8B2 SVOPL MFSD12 SLC47A2 ITPR1 SLC2A10 SLC7A4 CCT8L2 KCNA6 CLCN5 KCNC3 SLC17A1 SLC49A4 TMC8 SLC25A38 OSBPL8 KCNN1 KCNN2 KCNN3 SLC17A8 SLC37A2 SLC35F2 SLC49A3 SLC30A9 SVOP SLC16A10 | 7.78e-12 | 1289 | 131 | 33 | GO:0005215 |
| GeneOntologyMolecularFunction | transmembrane transporter activity | SLC38A9 SLC26A2 FLVCR1 TOMM20 ABCC9 SLC30A2 AQP3 SVOPL MFSD12 SLC47A2 ITPR1 SLC2A10 SLC7A4 CCT8L2 KCNA6 CLCN5 KCNC3 SLC17A1 SLC49A4 TMC8 SLC25A38 KCNN1 KCNN2 KCNN3 SLC17A8 SLC37A2 SLC35F2 SLC49A3 SLC30A9 SVOP SLC16A10 | 2.02e-11 | 1180 | 131 | 31 | GO:0022857 |
| GeneOntologyMolecularFunction | L-lactate dehydrogenase activity | 8.80e-09 | 5 | 131 | 4 | GO:0004459 | |
| GeneOntologyMolecularFunction | lactate dehydrogenase activity | 2.63e-08 | 6 | 131 | 4 | GO:0004457 | |
| GeneOntologyMolecularFunction | NAD binding | 5.06e-07 | 73 | 131 | 7 | GO:0051287 | |
| GeneOntologyMolecularFunction | small conductance calcium-activated potassium channel activity | 1.10e-06 | 4 | 131 | 3 | GO:0016286 | |
| GeneOntologyMolecularFunction | calcium-activated potassium channel activity | 1.68e-06 | 14 | 131 | 4 | GO:0015269 | |
| GeneOntologyMolecularFunction | inorganic molecular entity transmembrane transporter activity | SLC26A2 ABCC9 SLC30A2 AQP3 SLC47A2 ITPR1 SLC2A10 CCT8L2 KCNA6 CLCN5 KCNC3 SLC17A1 KCNN1 KCNN2 KCNN3 SLC17A8 SLC37A2 SLC30A9 | 2.33e-06 | 758 | 131 | 18 | GO:0015318 |
| GeneOntologyMolecularFunction | neuroligin family protein binding | 2.73e-06 | 5 | 131 | 3 | GO:0097109 | |
| GeneOntologyMolecularFunction | secondary active transmembrane transporter activity | SLC26A2 SLC30A2 MFSD12 SLC47A2 SLC2A10 CLCN5 SLC17A1 SLC17A8 SLC37A2 SLC30A9 SLC16A10 | 4.14e-06 | 296 | 131 | 11 | GO:0015291 |
| GeneOntologyMolecularFunction | alcohol binding | 4.90e-06 | 102 | 131 | 7 | GO:0043178 | |
| GeneOntologyMolecularFunction | ethanol binding | 5.44e-06 | 6 | 131 | 3 | GO:0035276 | |
| GeneOntologyMolecularFunction | active transmembrane transporter activity | SLC26A2 TOMM20 ABCC9 SLC30A2 MFSD12 SLC47A2 SLC2A10 CLCN5 SLC17A1 SLC17A8 SLC37A2 SLC30A9 SLC16A10 | 1.57e-05 | 477 | 131 | 13 | GO:0022804 |
| GeneOntologyMolecularFunction | all-trans-retinol dehydrogenase (NAD+) activity | 1.70e-05 | 24 | 131 | 4 | GO:0004745 | |
| GeneOntologyMolecularFunction | monoatomic ion transmembrane transporter activity | SLC26A2 ABCC9 SLC30A2 SLC47A2 ITPR1 SLC2A10 CCT8L2 KCNA6 CLCN5 KCNC3 SLC17A1 TMC8 KCNN1 KCNN2 KCNN3 SLC17A8 SLC30A9 | 1.73e-05 | 793 | 131 | 17 | GO:0015075 |
| GeneOntologyMolecularFunction | potassium channel activity | 2.18e-05 | 128 | 131 | 7 | GO:0005267 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase (NAD+) activity | 2.36e-05 | 26 | 131 | 4 | GO:0004022 | |
| GeneOntologyMolecularFunction | calcium-activated cation channel activity | 2.76e-05 | 27 | 131 | 4 | GO:0005227 | |
| GeneOntologyMolecularFunction | inward rectifier potassium channel activity | 3.21e-05 | 28 | 131 | 4 | GO:0005242 | |
| GeneOntologyMolecularFunction | alcohol dehydrogenase [NAD(P)+] activity | 4.25e-05 | 30 | 131 | 4 | GO:0018455 | |
| GeneOntologyMolecularFunction | Rab GDP-dissociation inhibitor activity | 4.27e-05 | 2 | 131 | 2 | GO:0005093 | |
| GeneOntologyMolecularFunction | monoatomic ion-gated channel activity | 4.85e-05 | 31 | 131 | 4 | GO:0022839 | |
| GeneOntologyMolecularFunction | voltage-gated potassium channel activity | 5.72e-05 | 102 | 131 | 6 | GO:0005249 | |
| GeneOntologyMolecularFunction | metal ion transmembrane transporter activity | ABCC9 SLC30A2 ITPR1 CCT8L2 KCNA6 KCNC3 SLC17A1 KCNN1 KCNN2 KCNN3 SLC17A8 SLC30A9 | 5.73e-05 | 465 | 131 | 12 | GO:0046873 |
| GeneOntologyMolecularFunction | protein tyrosine phosphatase activity | 6.04e-05 | 103 | 131 | 6 | GO:0004725 | |
| GeneOntologyMolecularFunction | inorganic cation transmembrane transporter activity | ABCC9 SLC30A2 SLC47A2 ITPR1 SLC2A10 CCT8L2 KCNA6 KCNC3 SLC17A1 KCNN1 KCNN2 KCNN3 SLC17A8 SLC30A9 | 6.53e-05 | 627 | 131 | 14 | GO:0022890 |
| GeneOntologyMolecularFunction | amino acid transmembrane transporter activity | 6.72e-05 | 105 | 131 | 6 | GO:0015171 | |
| GeneOntologyMolecularFunction | gated channel activity | 7.23e-05 | 334 | 131 | 10 | GO:0022836 | |
| GeneOntologyMolecularFunction | potassium ion transmembrane transporter activity | 1.18e-04 | 167 | 131 | 7 | GO:0015079 | |
| GeneOntologyMolecularFunction | monoatomic cation transmembrane transporter activity | ABCC9 SLC30A2 SLC47A2 ITPR1 SLC2A10 CCT8L2 KCNA6 KCNC3 SLC17A1 KCNN1 KCNN2 KCNN3 SLC17A8 SLC30A9 | 1.20e-04 | 664 | 131 | 14 | GO:0008324 |
| GeneOntologyMolecularFunction | monoamine oxidase activity | 1.28e-04 | 3 | 131 | 2 | GO:0097621 | |
| GeneOntologyMolecularFunction | 15-oxoprostaglandin 13-oxidase [NAD(P)+] activity | 1.28e-04 | 3 | 131 | 2 | GO:0047522 | |
| GeneOntologyMolecularFunction | oxidoreductase activity | IMPDH2 RNLS MAOB LDHAL6B PTGR2 HMGCR LDHA LDHB LDHC ADH1B ADH1C ADH4 ADH6 CRYL1 PTGR1 | 1.53e-04 | 766 | 131 | 15 | GO:0016491 |
| GeneOntologyMolecularFunction | transmembrane receptor protein tyrosine phosphatase activity | 1.75e-04 | 17 | 131 | 3 | GO:0005001 | |
| GeneOntologyMolecularFunction | transmembrane receptor protein phosphatase activity | 1.75e-04 | 17 | 131 | 3 | GO:0019198 | |
| GeneOntologyMolecularFunction | channel activity | ABCC9 AQP3 ITPR1 CCT8L2 KCNA6 CLCN5 KCNC3 TMC8 KCNN1 KCNN2 KCNN3 SLC17A8 | 1.79e-04 | 525 | 131 | 12 | GO:0015267 |
| GeneOntologyMolecularFunction | passive transmembrane transporter activity | ABCC9 AQP3 ITPR1 CCT8L2 KCNA6 CLCN5 KCNC3 TMC8 KCNN1 KCNN2 KCNN3 SLC17A8 | 1.82e-04 | 526 | 131 | 12 | GO:0022803 |
| GeneOntologyMolecularFunction | voltage-gated monoatomic ion channel activity | 2.01e-04 | 182 | 131 | 7 | GO:0005244 | |
| GeneOntologyMolecularFunction | voltage-gated channel activity | 2.15e-04 | 184 | 131 | 7 | GO:0022832 | |
| GeneOntologyMolecularFunction | organic cation transmembrane transporter activity | 2.17e-04 | 83 | 131 | 5 | GO:0015101 | |
| GeneOntologyMolecularFunction | monoatomic ion channel activity | ABCC9 ITPR1 CCT8L2 KCNA6 CLCN5 KCNC3 TMC8 KCNN1 KCNN2 KCNN3 SLC17A8 | 2.24e-04 | 459 | 131 | 11 | GO:0005216 |
| GeneOntologyMolecularFunction | antiporter activity | 3.01e-04 | 138 | 131 | 6 | GO:0015297 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic cation channel activity | 3.25e-04 | 140 | 131 | 6 | GO:0099094 | |
| GeneOntologyMolecularFunction | calcium channel regulator activity | 4.34e-04 | 54 | 131 | 4 | GO:0005246 | |
| GeneOntologyMolecularFunction | voltage-gated monoatomic cation channel activity | 5.04e-04 | 152 | 131 | 6 | GO:0022843 | |
| GeneOntologyMolecularFunction | phosphate transmembrane transporter activity | 5.05e-04 | 24 | 131 | 3 | GO:0005315 | |
| GeneOntologyMolecularFunction | ion channel regulator activity | 7.05e-04 | 162 | 131 | 6 | GO:0099106 | |
| GeneOntologyMolecularFunction | organic anion transmembrane transporter activity | SLC38A9 SLC26A2 MFSD12 SLC2A10 SLC25A38 SLC17A8 SLC37A2 SLC16A10 | 7.12e-04 | 293 | 131 | 8 | GO:0008514 |
| GeneOntologyMolecularFunction | inorganic anion transmembrane transporter activity | 9.34e-04 | 171 | 131 | 6 | GO:0015103 | |
| GeneOntologyMolecularFunction | channel regulator activity | 1.02e-03 | 174 | 131 | 6 | GO:0016247 | |
| GeneOntologyMolecularFunction | transporter regulator activity | 1.12e-03 | 177 | 131 | 6 | GO:0141108 | |
| GeneOntologyMolecularFunction | L-amino acid transmembrane transporter activity | 1.22e-03 | 71 | 131 | 4 | GO:0015179 | |
| GeneOntologyMolecularFunction | phosphoprotein phosphatase activity | 1.56e-03 | 189 | 131 | 6 | GO:0004721 | |
| GeneOntologyMolecularFunction | ligand-gated monoatomic ion channel activity | 1.74e-03 | 193 | 131 | 6 | GO:0015276 | |
| GeneOntologyMolecularFunction | ubiquitin-like modifier activating enzyme activity | 1.86e-03 | 10 | 131 | 2 | GO:0008641 | |
| GeneOntologyMolecularFunction | ligand-gated channel activity | 1.93e-03 | 197 | 131 | 6 | GO:0022834 | |
| GeneOntologyMolecularFunction | monoatomic cation channel activity | 1.94e-03 | 343 | 131 | 8 | GO:0005261 | |
| GeneOntologyMolecularFunction | ligase activity, forming carbon-sulfur bonds | 2.45e-03 | 41 | 131 | 3 | GO:0016877 | |
| GeneOntologyMolecularFunction | neutral L-amino acid transmembrane transporter activity | 2.45e-03 | 41 | 131 | 3 | GO:0015175 | |
| GeneOntologyMolecularFunction | carboxylic acid transmembrane transporter activity | 2.47e-03 | 207 | 131 | 6 | GO:0046943 | |
| GeneOntologyMolecularFunction | organic acid transmembrane transporter activity | 2.53e-03 | 208 | 131 | 6 | GO:0005342 | |
| GeneOntologyMolecularFunction | sodium:phosphate symporter activity | 2.70e-03 | 12 | 131 | 2 | GO:0005436 | |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors, oxygen as acceptor | 4.83e-03 | 16 | 131 | 2 | GO:0016641 | |
| GeneOntologyMolecularFunction | GDP-dissociation inhibitor activity | 5.45e-03 | 17 | 131 | 2 | GO:0005092 | |
| GeneOntologyMolecularFunction | cell adhesion molecule binding | LDHA PROM1 NRXN3 PTPRD PTPRF NRXN1 NRXN2 PTPRZ1 CD151 VSIG10L2 | 6.16e-03 | 599 | 131 | 10 | GO:0050839 |
| GeneOntologyMolecularFunction | cholesterol binding | 6.55e-03 | 58 | 131 | 3 | GO:0015485 | |
| GeneOntologyMolecularFunction | ATP-dependent activity | UBA5 ACSL6 ATG7 COQ8B KIF12 TOMM20 ABCC9 ATP8B2 CCT8L2 SLFN11 | 7.28e-03 | 614 | 131 | 10 | GO:0140657 |
| GeneOntologyMolecularFunction | oxidoreductase activity, acting on the CH-NH2 group of donors | 7.51e-03 | 20 | 131 | 2 | GO:0016638 | |
| GeneOntologyMolecularFunction | basic amino acid transmembrane transporter activity | 7.51e-03 | 20 | 131 | 2 | GO:0015174 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound metabolic process | RNLS MAOB GPR37 LDHAL6B ALG11 HMGCR LDHA COQ2 LDHB LDHC MFSD12 AWAT2 ADH1B ADH1C ADH4 ADH6 PTGR1 SLC37A2 SLC16A10 | 2.39e-08 | 641 | 131 | 19 | GO:1901615 |
| GeneOntologyBiologicalProcess | quinone metabolic process | 5.66e-07 | 26 | 131 | 5 | GO:1901661 | |
| GeneOntologyBiologicalProcess | lactate biosynthetic process from pyruvate | 9.97e-07 | 4 | 131 | 3 | GO:0019244 | |
| GeneOntologyBiologicalProcess | postsynaptic density assembly | 2.30e-06 | 34 | 131 | 5 | GO:0097107 | |
| GeneOntologyBiologicalProcess | isoprenoid metabolic process | 3.90e-06 | 144 | 131 | 8 | GO:0006720 | |
| GeneOntologyBiologicalProcess | postsynaptic specialization assembly | 8.52e-06 | 44 | 131 | 5 | GO:0098698 | |
| GeneOntologyBiologicalProcess | lactate biosynthetic process | 8.60e-06 | 7 | 131 | 3 | GO:0019249 | |
| GeneOntologyBiologicalProcess | excitatory synapse assembly | 1.06e-05 | 46 | 131 | 5 | GO:1904861 | |
| GeneOntologyBiologicalProcess | lactate metabolic process | 1.77e-05 | 25 | 131 | 4 | GO:0006089 | |
| GeneOntologyBiologicalProcess | retinol metabolic process | 2.15e-05 | 53 | 131 | 5 | GO:0042572 | |
| GeneOntologyBiologicalProcess | postsynapse assembly | 2.84e-05 | 93 | 131 | 6 | GO:0099068 | |
| GeneOntologyBiologicalProcess | postsynaptic density organization | 3.35e-05 | 58 | 131 | 5 | GO:0097106 | |
| GeneOntologyBiologicalProcess | adult behavior | 4.72e-05 | 203 | 131 | 8 | GO:0030534 | |
| GeneOntologyBiologicalProcess | monoatomic ion transport | MAOB SLC26A2 FLVCR1 ABCC9 SLC30A2 ATP8B2 CLDN10 SLC47A2 ITPR1 SLC2A10 PTPN3 CCT8L2 KCNA6 CLCN5 KCNC3 SLC17A1 TMC8 KCNN1 KCNN2 KCNN3 SLC17A8 SLC30A9 | 5.22e-05 | 1374 | 131 | 22 | GO:0006811 |
| GeneOntologyBiologicalProcess | inorganic ion transmembrane transport | SLC26A2 ABCC9 SLC30A2 SLC47A2 ITPR1 SLC2A10 PTPN3 CCT8L2 KCNA6 CLCN5 KCNC3 SLC17A1 KCNN1 KCNN2 KCNN3 SLC17A8 SLC37A2 SLC30A9 | 7.78e-05 | 1017 | 131 | 18 | GO:0098660 |
| GeneOntologyBiologicalProcess | monoatomic ion transmembrane transport | SLC26A2 ABCC9 SLC30A2 ATP8B2 SLC47A2 ITPR1 SLC2A10 PTPN3 CCT8L2 KCNA6 CLCN5 KCNC3 SLC17A1 TMC8 KCNN1 KCNN2 KCNN3 SLC17A8 SLC30A9 | 8.00e-05 | 1115 | 131 | 19 | GO:0034220 |
| GeneOntologyBiologicalProcess | postsynaptic specialization organization | 8.91e-05 | 71 | 131 | 5 | GO:0099084 | |
| GeneOntologyBiologicalProcess | amino acid transmembrane transport | 1.18e-04 | 120 | 131 | 6 | GO:0003333 | |
| GeneOntologyBiologicalProcess | acetaldehyde biosynthetic process | 1.20e-04 | 3 | 131 | 2 | GO:0046186 | |
| GeneOntologyBiologicalProcess | neuron cell-cell adhesion | 1.32e-04 | 16 | 131 | 3 | GO:0007158 | |
| GeneOntologyBiologicalProcess | synaptic membrane adhesion | 1.44e-04 | 42 | 131 | 4 | GO:0099560 | |
| GeneOntologyBiologicalProcess | synapse assembly | 1.58e-04 | 308 | 131 | 9 | GO:0007416 | |
| GeneOntologyBiologicalProcess | cell-cell adhesion via plasma-membrane adhesion molecules | 1.78e-04 | 313 | 131 | 9 | GO:0098742 | |
| GeneOntologyBiologicalProcess | regulation of postsynapse organization | 1.83e-04 | 185 | 131 | 7 | GO:0099175 | |
| GeneOntologyBiologicalProcess | ethanol metabolic process | 1.91e-04 | 18 | 131 | 3 | GO:0006067 | |
| GeneOntologyBiologicalProcess | monocarboxylic acid metabolic process | ACSL6 LDHAL6B PTGR2 ABCC9 LDHA LDHB LDHC MLYCD ADH1B ADH1C ADH4 ADH6 CRYL1 PTGR1 | 2.32e-04 | 731 | 131 | 14 | GO:0032787 |
| GeneOntologyBiologicalProcess | neuroligin clustering involved in postsynaptic membrane assembly | 2.38e-04 | 4 | 131 | 2 | GO:0097118 | |
| GeneOntologyBiologicalProcess | pyruvate catabolic process | 2.38e-04 | 4 | 131 | 2 | GO:0042867 | |
| GeneOntologyBiologicalProcess | retinoid metabolic process | 2.59e-04 | 89 | 131 | 5 | GO:0001523 | |
| GeneOntologyBiologicalProcess | ubiquinone metabolic process | 2.64e-04 | 20 | 131 | 3 | GO:0006743 | |
| GeneOntologyBiologicalProcess | cell junction assembly | CLDN18 PCDHB9 PCDHB2 LRTM2 CLDN10 RHOG NRXN3 PTPRD NRXN1 NRXN2 PTPRS CLDN20 | 2.79e-04 | 569 | 131 | 12 | GO:0034329 |
| GeneOntologyBiologicalProcess | phenol-containing compound metabolic process | 2.96e-04 | 142 | 131 | 6 | GO:0018958 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density assembly | 3.06e-04 | 21 | 131 | 3 | GO:0099151 | |
| GeneOntologyBiologicalProcess | organic cation transport | 3.31e-04 | 145 | 131 | 6 | GO:0015695 | |
| GeneOntologyBiologicalProcess | diterpenoid metabolic process | 3.34e-04 | 94 | 131 | 5 | GO:0016101 | |
| GeneOntologyBiologicalProcess | import into the mitochondrion | 3.84e-04 | 54 | 131 | 4 | GO:0170036 | |
| GeneOntologyBiologicalProcess | gephyrin clustering involved in postsynaptic density assembly | 3.95e-04 | 5 | 131 | 2 | GO:0097116 | |
| GeneOntologyBiologicalProcess | acetaldehyde metabolic process | 3.95e-04 | 5 | 131 | 2 | GO:0006117 | |
| GeneOntologyBiologicalProcess | vocalization behavior | 4.60e-04 | 24 | 131 | 3 | GO:0071625 | |
| GeneOntologyBiologicalProcess | terpenoid metabolic process | 5.56e-04 | 105 | 131 | 5 | GO:0006721 | |
| GeneOntologyBiologicalProcess | primary alcohol metabolic process | 5.81e-04 | 106 | 131 | 5 | GO:0034308 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic specialization assembly | 5.85e-04 | 26 | 131 | 3 | GO:0099150 | |
| GeneOntologyBiologicalProcess | regulation of excitatory synapse assembly | 5.85e-04 | 26 | 131 | 3 | GO:1904889 | |
| GeneOntologyBiologicalProcess | calcium-independent cell-cell adhesion via plasma membrane cell-adhesion molecules | 5.85e-04 | 26 | 131 | 3 | GO:0016338 | |
| GeneOntologyBiologicalProcess | regulation of postsynaptic density organization | 6.55e-04 | 27 | 131 | 3 | GO:1905874 | |
| GeneOntologyBiologicalProcess | potassium ion transmembrane transport | 7.13e-04 | 232 | 131 | 7 | GO:0071805 | |
| GeneOntologyBiologicalProcess | inorganic cation transmembrane transport | ABCC9 SLC30A2 SLC47A2 ITPR1 SLC2A10 PTPN3 CCT8L2 KCNA6 KCNC3 SLC17A1 KCNN1 KCNN2 KCNN3 SLC17A8 SLC30A9 | 7.68e-04 | 922 | 131 | 15 | GO:0098662 |
| GeneOntologyBiologicalProcess | vocal learning | 8.23e-04 | 7 | 131 | 2 | GO:0042297 | |
| GeneOntologyBiologicalProcess | cell surface receptor protein tyrosine phosphatase signaling pathway | 8.23e-04 | 7 | 131 | 2 | GO:0007185 | |
| GeneOntologyBiologicalProcess | imitative learning | 8.23e-04 | 7 | 131 | 2 | GO:0098596 | |
| GeneOntologyBiologicalProcess | postsynapse organization | 8.86e-04 | 313 | 131 | 8 | GO:0099173 | |
| GeneOntologyBiologicalProcess | monoatomic cation transmembrane transport | ABCC9 SLC30A2 SLC47A2 ITPR1 SLC2A10 PTPN3 CCT8L2 KCNA6 KCNC3 SLC17A1 KCNN1 KCNN2 KCNN3 SLC17A8 SLC30A9 | 9.54e-04 | 942 | 131 | 15 | GO:0098655 |
| GeneOntologyBiologicalProcess | regulation of synapse structure or activity | 9.59e-04 | 395 | 131 | 9 | GO:0050803 | |
| GeneOntologyBiologicalProcess | phosphate ion transport | 9.88e-04 | 31 | 131 | 3 | GO:0006817 | |
| GeneOntologyBiologicalProcess | cerebellar cortex development | 1.09e-03 | 71 | 131 | 4 | GO:0021695 | |
| GeneOntologyBiologicalProcess | positive regulation of catecholamine metabolic process | 1.09e-03 | 8 | 131 | 2 | GO:0045915 | |
| GeneOntologyBiologicalProcess | positive regulation of dopamine metabolic process | 1.09e-03 | 8 | 131 | 2 | GO:0045964 | |
| GeneOntologyBiologicalProcess | monoatomic anion transport | 1.12e-03 | 183 | 131 | 6 | GO:0006820 | |
| GeneOntologyBiologicalProcess | organic hydroxy compound catabolic process | 1.21e-03 | 73 | 131 | 4 | GO:1901616 | |
| GeneOntologyCellularComponent | synaptic membrane | NRP2 ITPR1 NRXN3 PTPRD PTPRF NRXN1 NRXN2 KCNC3 PTPRS PTPRZ1 KCNN2 CLMP SEZ6L | 9.80e-05 | 583 | 134 | 13 | GO:0097060 |
| MousePheno | decreased synaptic glutamate release | 1.77e-05 | 8 | 97 | 3 | MP:0004495 | |
| Domain | MFS | FLVCR1 MFSD6L SVOPL MFSD12 SLC2A10 SLC17A1 SLC49A4 SLC17A8 SLC37A2 SLC49A3 SVOP SLC16A10 | 1.11e-11 | 108 | 129 | 12 | PS50850 |
| Domain | MFS_dom | FLVCR1 MFSD6L SVOPL MFSD12 SLC2A10 SLC17A1 SLC49A4 SLC17A8 SLC37A2 SLC49A3 SVOP SLC16A10 | 1.45e-10 | 134 | 129 | 12 | IPR020846 |
| Domain | - | UBA5 ATG7 LDHAL6B PTGR2 LDHA LDHB LDHC ADH1B ADH1C ADH4 ADH6 CRYL1 PTGR1 | 1.63e-10 | 169 | 129 | 13 | 3.40.50.720 |
| Domain | NAD(P)-bd_dom | UBA5 ATG7 LDHAL6B PTGR2 LDHA LDHB LDHC ADH1B ADH1C ADH4 ADH6 CRYL1 PTGR1 | 2.18e-10 | 173 | 129 | 13 | IPR016040 |
| Domain | - | 1.67e-09 | 18 | 129 | 6 | 3.90.180.10 | |
| Domain | ADH_zinc_N | 2.43e-09 | 19 | 129 | 6 | PF00107 | |
| Domain | ADH_SF_Zn-type | 2.43e-09 | 19 | 129 | 6 | IPR002085 | |
| Domain | ADH_C | 2.43e-09 | 19 | 129 | 6 | IPR013149 | |
| Domain | MFS_1 | FLVCR1 SVOPL MFSD12 SLC17A1 SLC17A8 SLC37A2 SLC49A3 SVOP SLC16A10 | 2.93e-09 | 77 | 129 | 9 | PF07690 |
| Domain | MFS | FLVCR1 SVOPL MFSD12 SLC17A1 SLC17A8 SLC37A2 SLC49A3 SVOP SLC16A10 | 2.93e-09 | 77 | 129 | 9 | IPR011701 |
| Domain | L-lactate_DH | 1.08e-08 | 5 | 129 | 4 | IPR011304 | |
| Domain | L-lactate_DH_AS | 1.08e-08 | 5 | 129 | 4 | IPR018177 | |
| Domain | L_LDH | 1.08e-08 | 5 | 129 | 4 | PS00064 | |
| Domain | GroES-like | 1.17e-08 | 24 | 129 | 6 | IPR011032 | |
| Domain | PKS_ER | 5.98e-08 | 16 | 129 | 5 | SM00829 | |
| Domain | PKS_ER | 5.98e-08 | 16 | 129 | 5 | IPR020843 | |
| Domain | L-lactate/malate_DH | 1.49e-07 | 8 | 129 | 4 | IPR001557 | |
| Domain | Ldh_1_N | 1.49e-07 | 8 | 129 | 4 | PF00056 | |
| Domain | Lactate/malate_DH_N | 1.49e-07 | 8 | 129 | 4 | IPR001236 | |
| Domain | ADH_Zn_CS | 1.49e-07 | 8 | 129 | 4 | IPR002328 | |
| Domain | ADH_ZINC | 1.49e-07 | 8 | 129 | 4 | PS00059 | |
| Domain | PTPc | 1.59e-07 | 36 | 129 | 6 | SM00194 | |
| Domain | TYR_PHOSPHATASE_PTP | 2.61e-07 | 39 | 129 | 6 | PS50055 | |
| Domain | - | 2.66e-07 | 9 | 129 | 4 | 3.90.110.10 | |
| Domain | Lactate/malate_DH_C | 2.66e-07 | 9 | 129 | 4 | IPR022383 | |
| Domain | Lactate_DH/Glyco_Ohase_4_C | 2.66e-07 | 9 | 129 | 4 | IPR015955 | |
| Domain | Ldh_1_C | 2.66e-07 | 9 | 129 | 4 | PF02866 | |
| Domain | PTPase_domain | 3.56e-07 | 41 | 129 | 6 | IPR000242 | |
| Domain | Y_phosphatase | 3.56e-07 | 41 | 129 | 6 | PF00102 | |
| Domain | CaMBD | 1.28e-06 | 4 | 129 | 3 | PF02888 | |
| Domain | CaM-bd_dom | 1.28e-06 | 4 | 129 | 3 | IPR004178 | |
| Domain | CaMBD | 1.28e-06 | 4 | 129 | 3 | SM01053 | |
| Domain | SK_channel | 1.28e-06 | 4 | 129 | 3 | PF03530 | |
| Domain | K_chnl_Ca-activ_SK | 1.28e-06 | 4 | 129 | 3 | IPR015449 | |
| Domain | PTPc_motif | 3.22e-06 | 59 | 129 | 6 | SM00404 | |
| Domain | Tyr_Pase_cat | 3.22e-06 | 59 | 129 | 6 | IPR003595 | |
| Domain | ADH_N | 3.71e-06 | 16 | 129 | 4 | PF08240 | |
| Domain | ADH_N | 3.71e-06 | 16 | 129 | 4 | IPR013154 | |
| Domain | Syndecan | 1.10e-05 | 7 | 129 | 3 | PF01034 | |
| Domain | Syndecan/Neurexin_dom | 1.10e-05 | 7 | 129 | 3 | IPR027789 | |
| Domain | Tyr_Pase_AS | 1.13e-05 | 73 | 129 | 6 | IPR016130 | |
| Domain | TYR_PHOSPHATASE_1 | 2.89e-05 | 86 | 129 | 6 | PS00383 | |
| Domain | TYR_PHOSPHATASE_2 | 3.09e-05 | 87 | 129 | 6 | PS50056 | |
| Domain | TYR_PHOSPHATASE_dom | 3.09e-05 | 87 | 129 | 6 | IPR000387 | |
| Domain | - | 4.24e-05 | 92 | 129 | 6 | 3.90.190.10 | |
| Domain | RabGDI | 4.73e-05 | 2 | 129 | 2 | IPR000806 | |
| Domain | Tyr_Pase_non-rcpt_typ-3/4 | 4.73e-05 | 2 | 129 | 2 | IPR012151 | |
| Domain | Prot-tyrosine_phosphatase-like | 6.40e-05 | 99 | 129 | 6 | IPR029021 | |
| Domain | Neurexin-like | 1.11e-04 | 14 | 129 | 3 | IPR003585 | |
| Domain | 4.1m | 1.11e-04 | 14 | 129 | 3 | SM00294 | |
| Domain | RIBOSOMAL_S4E | 1.41e-04 | 3 | 129 | 2 | PS00528 | |
| Domain | 40S_S4_C | 1.41e-04 | 3 | 129 | 2 | IPR032277 | |
| Domain | Ribosomal_S4e_N_CS | 1.41e-04 | 3 | 129 | 2 | IPR018199 | |
| Domain | RS4NT | 1.41e-04 | 3 | 129 | 2 | PF08071 | |
| Domain | Ribosomal_S4e_central_region | 1.41e-04 | 3 | 129 | 2 | IPR013845 | |
| Domain | Ribosomal_S4e_N | 1.41e-04 | 3 | 129 | 2 | IPR013843 | |
| Domain | Ribosomal_S4e_central | 1.41e-04 | 3 | 129 | 2 | PD002667 | |
| Domain | Ribosomal_S4e | 1.41e-04 | 3 | 129 | 2 | IPR000876 | |
| Domain | Ribosomal_S4e | 1.41e-04 | 3 | 129 | 2 | PF00900 | |
| Domain | 40S_S4_C | 1.41e-04 | 3 | 129 | 2 | PF16121 | |
| Domain | GDI | 2.81e-04 | 4 | 129 | 2 | PF00996 | |
| Domain | GDP_dissociation_inhibitor | 2.81e-04 | 4 | 129 | 2 | IPR018203 | |
| Domain | K_chnl_dom | 3.91e-04 | 21 | 129 | 3 | IPR013099 | |
| Domain | Ion_trans_2 | 3.91e-04 | 21 | 129 | 3 | PF07885 | |
| Domain | Claudin_CS | 4.50e-04 | 22 | 129 | 3 | IPR017974 | |
| Domain | CLAUDIN | 4.50e-04 | 22 | 129 | 3 | PS01346 | |
| Domain | S4 | 4.67e-04 | 5 | 129 | 2 | PS50889 | |
| Domain | S4 | 4.67e-04 | 5 | 129 | 2 | SM00363 | |
| Domain | - | 6.04e-04 | 56 | 129 | 4 | 3.50.50.60 | |
| Domain | FAD/NAD-binding_dom | 6.46e-04 | 57 | 129 | 4 | IPR023753 | |
| Domain | S4_RNA-bd | 6.97e-04 | 6 | 129 | 2 | IPR002942 | |
| Domain | Claudin | 9.29e-04 | 28 | 129 | 3 | IPR006187 | |
| Domain | IGv | 1.81e-03 | 75 | 129 | 4 | SM00406 | |
| Domain | MFS_sugar_transport-like | 1.95e-03 | 36 | 129 | 3 | IPR005828 | |
| Domain | Sugar_tr | 1.95e-03 | 36 | 129 | 3 | PF00083 | |
| Domain | Cation_efflux | 2.05e-03 | 10 | 129 | 2 | IPR002524 | |
| Domain | ThiF_NAD_FAD-bd | 2.05e-03 | 10 | 129 | 2 | IPR000594 | |
| Domain | Cation_efflux | 2.05e-03 | 10 | 129 | 2 | PF01545 | |
| Domain | Amino_oxidase | 2.05e-03 | 10 | 129 | 2 | IPR002937 | |
| Domain | ThiF | 2.05e-03 | 10 | 129 | 2 | PF00899 | |
| Domain | Amino_oxidase | 2.05e-03 | 10 | 129 | 2 | PF01593 | |
| Domain | LAM_G_DOMAIN | 2.28e-03 | 38 | 129 | 3 | PS50025 | |
| Domain | KOW | 2.50e-03 | 11 | 129 | 2 | IPR005824 | |
| Domain | - | 2.50e-03 | 11 | 129 | 2 | 1.20.1510.10 | |
| Domain | KOW | 2.50e-03 | 11 | 129 | 2 | PF00467 | |
| Domain | Cation_efflux_TMD | 2.50e-03 | 11 | 129 | 2 | IPR027469 | |
| Domain | PMP22_Claudin | 2.64e-03 | 40 | 129 | 3 | PF00822 | |
| Domain | Laminin_G_2 | 2.64e-03 | 40 | 129 | 3 | PF02210 | |
| Domain | LamG | 3.47e-03 | 44 | 129 | 3 | SM00282 | |
| Domain | PMP22/EMP/MP20/Claudin | 3.70e-03 | 45 | 129 | 3 | IPR004031 | |
| Domain | EamA_dom | 4.08e-03 | 14 | 129 | 2 | IPR000620 | |
| Domain | EamA | 4.08e-03 | 14 | 129 | 2 | PF00892 | |
| Domain | ConA-like_dom | 4.18e-03 | 219 | 129 | 6 | IPR013320 | |
| Domain | CBS | 5.33e-03 | 16 | 129 | 2 | SM00116 | |
| Domain | - | 5.56e-03 | 52 | 129 | 3 | 2.60.120.290 | |
| Domain | CUB | 5.86e-03 | 53 | 129 | 3 | PS01180 | |
| Pathway | KEGG_GLYCOLYSIS_GLUCONEOGENESIS | 1.10e-08 | 62 | 99 | 8 | M11521 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 1.08e-06 | 12 | 99 | 4 | M14663 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 2.94e-06 | 15 | 99 | 4 | M39717 | |
| Pathway | KEGG_PROPANOATE_METABOLISM | 3.13e-06 | 33 | 99 | 5 | M4086 | |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 7.27e-06 | 67 | 99 | 6 | MM15327 | |
| Pathway | KEGG_TYROSINE_METABOLISM | 1.07e-05 | 42 | 99 | 5 | M16743 | |
| Pathway | KEGG_FATTY_ACID_METABOLISM | 1.07e-05 | 42 | 99 | 5 | M699 | |
| Pathway | SIG_CHEMOTAXIS | 1.51e-05 | 45 | 99 | 5 | M5193 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | ABCC9 NRXN3 PTPRD KCNA6 PTPRF NRXN1 NRXN2 KCNC3 PTPRS KCNN1 KCNN3 | 2.26e-05 | 335 | 99 | 11 | MM14503 |
| Pathway | KEGG_MEDICUS_REFERENCE_GLYCOLYSIS | 2.58e-05 | 25 | 99 | 4 | M47623 | |
| Pathway | REACTOME_CA2_ACTIVATED_K_CHANNELS | 2.74e-05 | 9 | 99 | 3 | M26932 | |
| Pathway | REACTOME_NEURONAL_SYSTEM | ABCC9 NRXN3 PTPRD KCNA6 PTPRF NRXN1 NRXN2 KCNC3 PTPRS KCNN1 KCNN2 KCNN3 | 3.00e-05 | 411 | 99 | 12 | M735 |
| Pathway | REACTOME_PROTEIN_PROTEIN_INTERACTIONS_AT_SYNAPSES | 3.29e-05 | 87 | 99 | 6 | M27617 | |
| Pathway | WP_HIPPOCAMPAL_SYNAPTOGENESIS_AND_NEUROGENESIS | 3.55e-05 | 27 | 99 | 4 | M45550 | |
| Pathway | WP_FATTY_ACID_OMEGAOXIDATION | 3.89e-05 | 10 | 99 | 3 | MM15833 | |
| Pathway | KEGG_CELL_ADHESION_MOLECULES_CAMS | 4.11e-05 | 133 | 99 | 7 | M16476 | |
| Pathway | REACTOME_ETHANOL_OXIDATION | 5.32e-05 | 11 | 99 | 3 | MM15405 | |
| Pathway | REACTOME_BUTYROPHILIN_BTN_FAMILY_INTERACTIONS | 7.06e-05 | 12 | 99 | 3 | M27738 | |
| Pathway | KEGG_RETINOL_METABOLISM | 8.47e-05 | 64 | 99 | 5 | M9488 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 8.50e-05 | 103 | 99 | 6 | M1073 | |
| Pathway | KEGG_CYSTEINE_AND_METHIONINE_METABOLISM | 9.03e-05 | 34 | 99 | 4 | M10911 | |
| Pathway | WP_KREBS_CYCLE_DISORDERS | 9.13e-05 | 13 | 99 | 3 | M39769 | |
| Pathway | SIG_REGULATION_OF_THE_ACTIN_CYTOSKELETON_BY_RHO_GTPASES | 1.01e-04 | 35 | 99 | 4 | M16801 | |
| Pathway | KEGG_DRUG_METABOLISM_CYTOCHROME_P450 | 1.49e-04 | 72 | 99 | 5 | M9257 | |
| Pathway | KEGG_PYRUVATE_METABOLISM | 1.72e-04 | 40 | 99 | 4 | M7934 | |
| Pathway | REACTOME_PYRUVATE_METABOLISM | 2.50e-04 | 44 | 99 | 4 | MM15393 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 2.73e-04 | 45 | 99 | 4 | M39474 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 3.51e-04 | 20 | 99 | 3 | M27290 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 3.51e-04 | 20 | 99 | 3 | MM15485 | |
| Pathway | REACTOME_RECEPTOR_TYPE_TYROSINE_PROTEIN_PHOSPHATASES | 3.51e-04 | 20 | 99 | 3 | MM14991 | |
| Pathway | REACTOME_PYRUVATE_METABOLISM | 3.81e-04 | 49 | 99 | 4 | M17157 | |
| Pathway | REACTOME_SYNAPTIC_ADHESION_LIKE_MOLECULES | 4.08e-04 | 21 | 99 | 3 | M27736 | |
| Pathway | WP_GLYCOLYSIS_AND_GLUCONEOGENESIS | 4.44e-04 | 51 | 99 | 4 | MM15928 | |
| Pathway | REACTOME_POTASSIUM_CHANNELS | 6.25e-04 | 98 | 99 | 5 | MM14545 | |
| Pathway | REACTOME_CA2_ACTIVATED_K_CHANNELS | 7.19e-04 | 6 | 99 | 2 | MM14543 | |
| Pathway | REACTOME_PHASE_I_FUNCTIONALIZATION_OF_COMPOUNDS | 8.19e-04 | 104 | 99 | 5 | M738 | |
| Pathway | REACTOME_RA_BIOSYNTHESIS_PATHWAY | 9.69e-04 | 28 | 99 | 3 | MM15188 | |
| Pathway | WP_FERROPTOSIS | 1.05e-03 | 64 | 99 | 4 | M39768 | |
| Pathway | REACTOME_TIGHT_JUNCTION_INTERACTIONS | 1.19e-03 | 30 | 99 | 3 | M17967 | |
| Pathway | REACTOME_ABACAVIR_ADME | 1.33e-03 | 8 | 99 | 2 | MM14869 | |
| Pathway | REACTOME_NEUREXINS_AND_NEUROLIGINS | 1.44e-03 | 32 | 99 | 3 | MM15326 | |
| Pathway | KEGG_METABOLISM_OF_XENOBIOTICS_BY_CYTOCHROME_P450 | 1.47e-03 | 70 | 99 | 4 | M16794 | |
| Pathway | WP_DISRUPTION_OF_POSTSYNAPTIC_SIGNALING_BY_CNV | 1.57e-03 | 33 | 99 | 3 | M39875 | |
| Pathway | REACTOME_SLC_MEDIATED_TRANSMEMBRANE_TRANSPORT | 1.85e-03 | 249 | 99 | 7 | M5988 | |
| Pathway | REACTOME_TRANSPORT_OF_SMALL_MOLECULES | SLC26A2 FLVCR1 PSMD2 ABCC9 SLC30A2 AQP3 ATP8B2 SLC47A2 SLC2A10 CLCN5 SLC17A1 SLC17A8 SLC16A10 | 1.88e-03 | 736 | 99 | 13 | M27287 |
| Pubmed | 8.13e-14 | 8 | 134 | 6 | 37591863 | ||
| Pubmed | Merging protein, gene and genomic data: the evolution of the MDR-ADH family. | 3.14e-09 | 6 | 134 | 4 | 16121213 | |
| Pubmed | Human liver alcohol dehydrogenase: purification, composition, and catalytic features. | 3.14e-09 | 6 | 134 | 4 | 9982 | |
| Pubmed | 7.31e-09 | 7 | 134 | 4 | 11784316 | ||
| Pubmed | 7.31e-09 | 7 | 134 | 4 | 23456092 | ||
| Pubmed | Association between common alcohol dehydrogenase gene (ADH) variants and schizophrenia and autism. | 7.31e-09 | 7 | 134 | 4 | 23468174 | |
| Pubmed | Endogenous β-neurexins on axons and within synapses show regulated dynamic behavior. | 5.59e-08 | 3 | 134 | 3 | 34133920 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 38891114 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 15234350 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 11557517 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 11146124 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 34708888 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 16055520 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 22416006 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 30858964 | ||
| Pubmed | LAR receptor phospho-tyrosine phosphatases regulate NMDA-receptor responses. | 5.59e-08 | 3 | 134 | 3 | 31985401 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 20139422 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 9784606 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 12382077 | ||
| Pubmed | Intact synapse structure and function after combined knockout of PTPδ, PTPσ, and LAR. | 5.59e-08 | 3 | 134 | 3 | 33656439 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 28013231 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 16406382 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 17853776 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 31812984 | ||
| Pubmed | Properties of human testis-specific lactate dehydrogenase expressed from Escherichia coli. | 5.59e-08 | 3 | 134 | 3 | 1996957 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 2401207 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 15190101 | ||
| Pubmed | Structure and evolution of neurexin genes: insight into the mechanism of alternative splicing. | 5.59e-08 | 3 | 134 | 3 | 12036300 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 20689065 | ||
| Pubmed | β-Neurexins Control Neural Circuits by Regulating Synaptic Endocannabinoid Signaling. | 5.59e-08 | 3 | 134 | 3 | 26213384 | |
| Pubmed | Neurexin gene family variants as risk factors for autism spectrum disorder. | 5.59e-08 | 3 | 134 | 3 | 29045040 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 17178662 | ||
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 31005376 | ||
| Pubmed | Structural basis for altered activity of M- and H-isozyme forms of human lactate dehydrogenase. | 5.59e-08 | 3 | 134 | 3 | 11276087 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 38571813 | ||
| Pubmed | Alcohol dehydrogenase polymorphisms influence alcohol-elimination rates in a male Jewish population. | 5.59e-08 | 3 | 134 | 3 | 14745297 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 35173587 | ||
| Pubmed | Subcellular expression and neuroprotective effects of SK channels in human dopaminergic neurons. | 5.59e-08 | 3 | 134 | 3 | 24434522 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 22767497 | ||
| Pubmed | Neurexins are differentially expressed in the embryonic nervous system of mice. | 5.59e-08 | 3 | 134 | 3 | 7722633 | |
| Pubmed | Regulated Dynamic Trafficking of Neurexins Inside and Outside of Synaptic Terminals. | 5.59e-08 | 3 | 134 | 3 | 26446217 | |
| Pubmed | Analysis of the human neurexin genes: alternative splicing and the generation of protein diversity. | 5.59e-08 | 3 | 134 | 3 | 11944992 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 33058888 | ||
| Pubmed | Important contribution of alpha-neurexins to Ca2+-triggered exocytosis of secretory granules. | 5.59e-08 | 3 | 134 | 3 | 17035546 | |
| Pubmed | 5.59e-08 | 3 | 134 | 3 | 9448462 | ||
| Pubmed | Deletion of α-neurexin II results in autism-related behaviors in mice. | 5.59e-08 | 3 | 134 | 3 | 25423136 | |
| Pubmed | 1.11e-07 | 98 | 134 | 7 | 9507200 | ||
| Pubmed | Postsynaptic N-methyl-D-aspartate receptor function requires alpha-neurexins. | 2.23e-07 | 4 | 134 | 3 | 14983056 | |
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 11582518 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 32706374 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 29737974 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 11125887 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 8524829 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 8786425 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 17347997 | ||
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 12631290 | ||
| Pubmed | Neurexins cluster Ca2+ channels within the presynaptic active zone. | 2.23e-07 | 4 | 134 | 3 | 32134527 | |
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 12882916 | ||
| Pubmed | Primate-specific BTN3A2 protects against SARS-CoV-2 infection by interacting with and reducing ACE2. | 2.23e-07 | 4 | 134 | 3 | 39142074 | |
| Pubmed | 2.23e-07 | 4 | 134 | 3 | 35385735 | ||
| Pubmed | Neurexins regulate presynaptic GABAB-receptors at central synapses. | 2.23e-07 | 4 | 134 | 3 | 33888718 | |
| Pubmed | Ion channel expression in the developing enteric nervous system. | 3.11e-07 | 37 | 134 | 5 | 25798587 | |
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 29339503 | ||
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 28472659 | ||
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 36709330 | ||
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 11836246 | ||
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 20537373 | ||
| Pubmed | ADH single nucleotide polymorphism associations with alcohol metabolism in vivo. | 5.56e-07 | 5 | 134 | 3 | 19193628 | |
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 19861527 | ||
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 10777529 | ||
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 18996923 | ||
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 22357843 | ||
| Pubmed | Adh1 and Adh1/4 knockout mice as possible rodent models for presymptomatic Parkinson's disease. | 5.56e-07 | 5 | 134 | 3 | 22079585 | |
| Pubmed | Neuroligins and neurexins link synaptic function to cognitive disease. | 5.56e-07 | 5 | 134 | 3 | 18923512 | |
| Pubmed | 5.56e-07 | 5 | 134 | 3 | 9223334 | ||
| Pubmed | RPS4Y2 SLC26A2 RPS4X FLVCR1 PSMD2 LDHA GDI2 LDHB RHOG YIPF5 ERGIC3 OSBPL8 PRMT1 SLC35F2 SLC30A9 SLC16A10 | 8.75e-07 | 952 | 134 | 16 | 38569033 | |
| Pubmed | 1.11e-06 | 6 | 134 | 3 | 19273906 | ||
| Pubmed | 1.11e-06 | 6 | 134 | 3 | 17257171 | ||
| Pubmed | Alpha-neurexins couple Ca2+ channels to synaptic vesicle exocytosis. | 1.11e-06 | 6 | 134 | 3 | 12827191 | |
| Pubmed | 1.11e-06 | 6 | 134 | 3 | 12027900 | ||
| Pubmed | 1.11e-06 | 6 | 134 | 3 | 518534 | ||
| Pubmed | Structures, alternative splicing, and neurexin binding of multiple neuroligins. | 1.11e-06 | 6 | 134 | 3 | 8576240 | |
| Pubmed | 1.11e-06 | 6 | 134 | 3 | 30683685 | ||
| Pubmed | Multiple ADH genes modulate risk for drug dependence in both African- and European-Americans. | 1.11e-06 | 6 | 134 | 3 | 17185388 | |
| Pubmed | 1.11e-06 | 6 | 134 | 3 | 21858537 | ||
| Pubmed | Large-scale analysis of ion channel gene expression in the mouse heart during perinatal development. | 1.20e-06 | 139 | 134 | 7 | 16985003 | |
| Pubmed | 1.94e-06 | 7 | 134 | 3 | 29073098 | ||
| Pubmed | 1.94e-06 | 7 | 134 | 3 | 16047160 | ||
| Pubmed | 1.94e-06 | 7 | 134 | 3 | 12376545 | ||
| Pubmed | 1.94e-06 | 7 | 134 | 3 | 16685648 | ||
| Pubmed | The cluster of BTN genes in the extended major histocompatibility complex. | 1.94e-06 | 7 | 134 | 3 | 11170752 | |
| Pubmed | Neuroligin-1 Signaling Controls LTP and NMDA Receptors by Distinct Molecular Pathways. | 3.09e-06 | 8 | 134 | 3 | 30871858 | |
| Pubmed | 3.09e-06 | 8 | 134 | 3 | 18331377 | ||
| Pubmed | 3.09e-06 | 8 | 134 | 3 | 16382103 | ||
| Pubmed | 3.09e-06 | 8 | 134 | 3 | 28637841 | ||
| Pubmed | 4.62e-06 | 9 | 134 | 3 | 34919427 | ||
| Pubmed | 4.62e-06 | 9 | 134 | 3 | 17502376 | ||
| Pubmed | 4.62e-06 | 9 | 134 | 3 | 11747070 | ||
| Pubmed | 4.62e-06 | 9 | 134 | 3 | 9707552 | ||
| Pubmed | 5.34e-06 | 30 | 134 | 4 | 6375655 | ||
| Cytoband | Ensembl 112 genes in cytogenetic band chr4q23 | 4.25e-06 | 37 | 134 | 4 | chr4q23 | |
| Cytoband | 4q23 | 2.67e-05 | 20 | 134 | 3 | 4q23 | |
| GeneFamily | Solute carriers | SLC38A9 SLC26A2 FLVCR1 SLC30A2 SLC47A2 SLC35G4 SLC2A10 SLC7A4 SLC17A1 SLC49A4 SLC25A38 SLC35G5 SLC17A8 SLC37A2 SLC35F2 SLC49A3 SLC30A9 SLC16A10 | 1.17e-12 | 395 | 92 | 18 | 752 |
| GeneFamily | Alcohol dehydrogenases | 4.33e-08 | 8 | 92 | 4 | 397 | |
| GeneFamily | Potassium calcium-activated channels | 2.52e-06 | 6 | 92 | 3 | 255 | |
| GeneFamily | Protein tyrosine phosphatases, receptor type | 3.52e-06 | 21 | 92 | 4 | 813 | |
| GeneFamily | Butyrophilins|V-set domain containing|C2-set domain containing | 5.55e-05 | 15 | 92 | 3 | 458 | |
| GeneFamily | Claudins | 2.10e-04 | 23 | 92 | 3 | 488 | |
| GeneFamily | Ubiquitin like modifier activating enzymes | 1.12e-03 | 10 | 92 | 2 | 100 | |
| GeneFamily | Blood group antigens|CD molecules|I-set domain containing|Immunoglobulin like domain containing | 1.39e-03 | 161 | 92 | 5 | 593 | |
| GeneFamily | Protein tyrosine phosphatases, non-receptor type | 3.72e-03 | 18 | 92 | 2 | 812 | |
| GeneFamily | Rho family GTPases | 4.58e-03 | 20 | 92 | 2 | 390 | |
| GeneFamily | PDZ domain containing | 7.57e-03 | 152 | 92 | 4 | 1220 | |
| GeneFamily | Fibronectin type III domain containing | 9.03e-03 | 160 | 92 | 4 | 555 | |
| GeneFamily | WD repeat domain containing|Caspase recruitment domain containing|Apoptosome | 1.02e-02 | 30 | 92 | 2 | 959 | |
| Coexpression | GSE5589_UNSTIM_VS_180MIN_LPS_STIM_MACROPHAGE_UP | 8.82e-07 | 200 | 133 | 9 | M6600 | |
| Coexpression | TRAVAGLINI_LUNG_BASAL_CELL | 5.51e-06 | 188 | 133 | 8 | M41651 | |
| Coexpression | GSE7460_FOXP3_MUT_VS_WT_ACT_TCONV_UP | 8.66e-06 | 200 | 133 | 8 | M5700 | |
| Coexpression | MURARO_PANCREAS_ACINAR_CELL | IMPDH2 RPS4X CELA2A CASP4 LDHA SLC30A2 LDHB CLDN10 ADH1C CCND2 ARSD PTPRF PTGR1 CD151 | 2.22e-05 | 732 | 133 | 14 | M39174 |
| ToppCell | facs-Brain_Non-Myeloid-Cortex|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.47e-07 | 196 | 134 | 8 | 256fe9bc0815f66a9afe11ba3507ef1372b52fd3 | |
| ToppCell | healthy_donor-Lymphocytic|healthy_donor / Disease condition, Lineage, Cell class and subclass | 1.65e-07 | 199 | 134 | 8 | 2841e16d54acd344ba454f024e285c28abc37319 | |
| ToppCell | myeloid-Dendritic_cell-Conventional_dendritic_cell|myeloid / Lineage, cell class and subclass | 1.65e-07 | 199 | 134 | 8 | 1e7ce1a1d6a7af18351d64b7a5334efa6dd9abc5 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-07 | 171 | 134 | 7 | 6a0fafb8fd9fc7671618eeb2bf528ce8ce86b794 | |
| ToppCell | facs-Marrow-T-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 8.86e-07 | 171 | 134 | 7 | e02b5831768dbb1b68998b672e55c9680ab0cc86 | |
| ToppCell | 5'-Adult-LargeIntestine-Hematopoietic-Myeloid-Lymphoid_DC|Adult / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 9.96e-07 | 174 | 134 | 7 | 16204ff504b7b382b4d90ca35003ad5336020e07 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-06 | 176 | 134 | 7 | 74f851a398c7562dd713bc0d8d488c0037243112 | |
| ToppCell | facs-Marrow-T_cells-18m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.07e-06 | 176 | 134 | 7 | 31b5459a978d5cdde0af03a77401e0464d8c95ba | |
| ToppCell | COVID-19-kidney-tDL|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.25e-06 | 180 | 134 | 7 | 864c895b5eaedefae86f5829fa344f7b686fb59f | |
| ToppCell | E18.5-samps-Mesenchymal-Pericyte|E18.5-samps / Age Group, Lineage, Cell class and subclass | 1.25e-06 | 180 | 134 | 7 | 0b1d370db64862fe1c7ea0ffaf06d03ec82e6e70 | |
| ToppCell | facs-Marrow-KLS-3m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.34e-06 | 182 | 134 | 7 | e7138c8d3821b4141c4b1b23dab6d9b4e99fd4b2 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium-respiratory_basal_cell|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-06 | 185 | 134 | 7 | 10e8018e9e10a2ca59f700e8406e5d01a86d14b9 | |
| ToppCell | 5'-Parenchyma_lung-Epithelial-Airway_epithelium|5' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 1.50e-06 | 185 | 134 | 7 | 1c709081517970ce8fb2eb402fd879d23b83fb66 | |
| ToppCell | facs-Brain_Non-Myeloid-Striatum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.55e-06 | 186 | 134 | 7 | ac7a84b11b4550c4ac01eab370dc8ab88e4fb72b | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro-CMP|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 1.55e-06 | 186 | 134 | 7 | 895905f1d1a01ffd5617a0baa8818693a7e9cb3b | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Epithelial-Distal_tubule_epithelial_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 1.73e-06 | 189 | 134 | 7 | 55420853f730b433ef58ac9337ac84ac78a247a0 | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 1.73e-06 | 189 | 134 | 7 | 2a22b9fae70afb3dab8476f9c00e48a4df756410 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 190 | 134 | 7 | bfbdf16d488359d7935a419c4c1823288f39c183 | |
| ToppCell | facs-Heart-RA-3m-Mesenchymal-valve_cell|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.79e-06 | 190 | 134 | 7 | eb1f8bb4d903b08e50c2dc173b06c0c79d8e316e | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.85e-06 | 191 | 134 | 7 | fd345837bfc40d85256b9a7e4fd3343bcbfe0ae5 | |
| ToppCell | E15.5-Epithelial-alveolar_epithelial_cell|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.92e-06 | 192 | 134 | 7 | 567f4355a01aae1f2eafc16fe86d1538a62030ab | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.92e-06 | 192 | 134 | 7 | 12096302a3a4d26e21ca04357aa557143f482155 | |
| ToppCell | facs-Lung-18m-Epithelial|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 1.99e-06 | 193 | 134 | 7 | 8e934f127bc763e905c788beabfa867bd559b682 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.06e-06 | 194 | 134 | 7 | 60622bd2f75bfe4c37f721cb12f03dab33f2f58d | |
| ToppCell | E16.5-Epithelial|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.13e-06 | 195 | 134 | 7 | e2d9856e4bd6259f0988cfefd7ce364f15681bf8 | |
| ToppCell | COVID_non-vent-Lymphocytic-T_cell|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.13e-06 | 195 | 134 | 7 | 4bdedd924564a260841a9153604026b57487c83d | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-06 | 196 | 134 | 7 | 1756254a61ea92601ed5e223ef4471f010c12216 | |
| ToppCell | Megakaryocytic-erythropoietic-MEP-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 2.20e-06 | 196 | 134 | 7 | 4e97010185fa9392da8f69e7b2a7395bf063f8ff | |
| ToppCell | Megakaryocytic-erythropoietic-MEP|Megakaryocytic-erythropoietic / Lineage, cell class and subclass | 2.20e-06 | 196 | 134 | 7 | f90e7fe3a7b2fff30d01a25cc500876861c2e4f1 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar-Sox9_Epi|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-06 | 196 | 134 | 7 | b236be2fc0144c77a8840081bbb6ac6913e996f8 | |
| ToppCell | E16.5-Epithelial-Epithelial_Alveolar-Epithelial_Alveolar|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 2.20e-06 | 196 | 134 | 7 | caa3c9555e1c656e88246ed31388a818f77610a1 | |
| ToppCell | COVID_non-vent-Lymphocytic|COVID_non-vent / Disease condition, Lineage, Cell class and subclass | 2.28e-06 | 197 | 134 | 7 | c672915f8c8c1e948d251f6eaf9f84a5600c1193 | |
| ToppCell | healthy_donor-Lymphocytic-T_cell-CD4+_Naive_T_cell|healthy_donor / Disease condition, Lineage, Cell class and subclass | 2.28e-06 | 197 | 134 | 7 | cf72160f03105876641fa6fdc7405e339eb084c7 | |
| ToppCell | COVID_vent-Lymphocytic-T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.28e-06 | 197 | 134 | 7 | ad702e440a74d54cfdcb8bb1c66bd8e0e71ab04e | |
| ToppCell | COVID_vent-Lymphocytic-T_cell-CD4+_Memory_T_cell|COVID_vent / Disease condition, Lineage, Cell class and subclass | 2.35e-06 | 198 | 134 | 7 | 58f208b76cb0adcecdf632d92f92833a06f9bf71 | |
| ToppCell | 10x5'v1-week_12-13-Hematopoietic-HSC/MPP_and_pro|week_12-13 / cell types per 3 fetal stages;per 3',per 5' | 2.35e-06 | 198 | 134 | 7 | a5d66a80bbc1a5aa29d0b763ea9dc3044b8c263d | |
| ToppCell | 3'-Broncho-tracheal-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal-Suprabasal_L.0.0.1.0|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.35e-06 | 198 | 134 | 7 | b411fb9f16eb641593f546c5f3a0db37b05c1f4f | |
| ToppCell | 3'-Distal_airway-Epithelial-Airway_epithelium-respiratory_basal_cell-Suprabasal|3' / 5'-vs-3', Tissue groups, Lineages, Lineage subclass, Cell_type2, Cell_subtype2_L4.5 | 2.43e-06 | 199 | 134 | 7 | 8be5ebed3a4053715f69156bbbb159d501a5c197 | |
| ToppCell | myeloid-Dendritic_cell|myeloid / Lineage, cell class and subclass | 2.43e-06 | 199 | 134 | 7 | b81c0a40481f1006ac4aa8759af95448cb5fc2e6 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural-|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-06 | 154 | 134 | 6 | 30cb4bb297fa815adb829f3b5cafca56fcbcb810 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell-Schwann_Cell_/_Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-06 | 154 | 134 | 6 | ade094e2947761a0a34daa8fcff3e9ea8437e4a5 | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-06 | 154 | 134 | 6 | 42bd8f88fd075a2d4edde394785decad88a2660a | |
| ToppCell | renal_cortex_nuclei-Renal_AKI_(acute_kidney_injury)-Neural-neural_cell|Renal_AKI_(acute_kidney_injury) / Celltypes from Cells and Nuclei per compartment and clinical group | 7.30e-06 | 154 | 134 | 6 | 6425d9861148586466febd6eceae1b1f9b9a14c1 | |
| ToppCell | tumor_Lymph_Node_/_Brain-Myeloid_cells-CD1c+_DCs|Myeloid_cells / Location, Cell class and cell subclass | 8.76e-06 | 159 | 134 | 6 | b3c52908cd24bbf851fac69db3850fc7f53c2092 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Neurosecretory-Secretory|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.08e-06 | 160 | 134 | 6 | b4844a8c7755a2b2868019791d8d224154973445 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Neurosecretory-Secretory-Secretory_mature|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.08e-06 | 160 | 134 | 6 | 01ae730e9d0d05f3277f862f0c09bafb32b89db5 | |
| ToppCell | PND01-Epithelial-Epithelial_Airway-Neurosecretory|PND01 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 9.08e-06 | 160 | 134 | 6 | 6de9e7be1d860d82d503bfbc779e72f072a6efc3 | |
| ToppCell | E18.5-Mesenchymal-Mesenchymal_myocytic-Myofibroblast_vascular-Pericyte-Pericyte_prolif|E18.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.16e-05 | 167 | 134 | 6 | b0eb7a40491dd2432f5282f578ce569df86d21a7 | |
| ToppCell | P03-Epithelial-alveolar_epithelial_cell-type_II_pneumocyte|P03 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 1.28e-05 | 170 | 134 | 6 | 3fd37e9b377d6485cea1262c31a8507d18a78514 | |
| ToppCell | E16.5-Endothelial-Endothelial_blood-vessel-Macrovascular_EC-VEC-VEC_prolif|E16.5 / Age_group by Lineage, Lineage_subclass, Cell_type, subtypes-by-prolif | 1.37e-05 | 172 | 134 | 6 | 8a6a2b4c6654bc976e60a02d0e7303a9071ed55f | |
| ToppCell | facs-Brain_Non-Myeloid-Cerebellum-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.72e-05 | 179 | 134 | 6 | 7ae67e1c09a4ce9b3bcec4c48ee9cf2b1cb4e339 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-CD4+_macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 180 | 134 | 6 | bf8d13d4db1af55b8c9fe16aaccf8743e000e005 | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 180 | 134 | 6 | 839defb40f7cfb2711e9025194de636533f51bcd | |
| ToppCell | facs-Marrow-B-cells-3m-Myeloid-macrophage|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.77e-05 | 180 | 134 | 6 | 82965ed1b72a1873c24dd4553d39681596057316 | |
| ToppCell | Smart-start-Cell-Wel_seq-Neoplastic-Differentiated-like-MES-like-MES-like_hypoxia/MHC-G|Smart-start-Cell-Wel_seq / Platform, Oncotype, Lineage, Cell_class, celltype (level4), mutation group | 1.77e-05 | 180 | 134 | 6 | e4add4c94f892a2d93926e5c6dac6a738319d091 | |
| ToppCell | facs-Marrow-T_cells-18m-Hematologic-MPP_Fraction_B|Marrow / Spleen_Marrow_Thymus - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.83e-05 | 181 | 134 | 6 | 064057ab36c6d92c36572b73142b42d201709d7b | |
| ToppCell | 10x3'2.3-week_14-16-Hematopoietic-HSC/MPP_and_pro-MEP|week_14-16 / cell types per 3 fetal stages;per 3',per 5' | 1.83e-05 | 181 | 134 | 6 | ee207ea171e2ffc22a7f850be57bb118a87e0f81 | |
| ToppCell | droplet-Heart-4Chambers-18m-Neuronal-nan|Heart / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 1.95e-05 | 183 | 134 | 6 | 2df1611c8acccb2a6f233d3d68bd9df2381a7278 | |
| ToppCell | COVID-19-kidney-PCT-S1|COVID-19 / Disease (COVID-19 only), tissue and cell type | 1.95e-05 | 183 | 134 | 6 | 6878d14026c3df6aa12e45dfad94b32fa9d9b0b7 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 184 | 134 | 6 | 278a7ed764c326450cb70e69ed2175980eaf5fe0 | |
| ToppCell | COVID-19-kidney-PCT-S1/S2|kidney / Disease (COVID-19 only), tissue and cell type | 2.01e-05 | 184 | 134 | 6 | dc71f22583fc54b89b242cbb602f4bbe86f576ec | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 184 | 134 | 6 | 8d86e125257ff1d3af8d90577a8b3f0321eca21c | |
| ToppCell | droplet-Limb_Muscle-nan-18m-Macroglial-unknown|Limb_Muscle / Tongue_Heart_Limb_Muscle_Aorta_Diaphragm - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.01e-05 | 184 | 134 | 6 | a7399a72f065d68800e3e0b2031d9894e0cc0ba4 | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 185 | 134 | 6 | 8433a337625ff8398520e223ef92bf9bb0beb14c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-fibroblast|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 185 | 134 | 6 | 049d793d043d5d434f143025de49dd210d18756c | |
| ToppCell | facs-Skin-nan-24m-Mesenchymal-nan|Skin / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.07e-05 | 185 | 134 | 6 | 63200c42565eea596f9b00728e70e544b8d50a7f | |
| ToppCell | critical-Myeloid-pDC|Myeloid / Severity, Lineage and Cell class of Nasopharyngeal (NS) Samples from Patients and Controls | 2.07e-05 | 185 | 134 | 6 | 4a5d1d0a757f1f4fdb911be96ed90b52182c25f0 | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E-|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.13e-05 | 186 | 134 | 6 | 1bac7825c2fe3e6cdff65026b09b9ccaa40fa27f | |
| ToppCell | PCW_05-06-Mesenchymal-Mesenchymal_fibroblastic-mes_immature_COL13A1^pos_fibro2_(5)|PCW_05-06 / Celltypes from embryonic and fetal-stage human lung | 2.13e-05 | 186 | 134 | 6 | 7def03dd856b765bd3f493288641981c4f7fd26e | |
| ToppCell | 343B-Fibroblasts-Fibroblast-E|343B / Donor, Lineage, Cell class and subclass (all cells) | 2.13e-05 | 186 | 134 | 6 | 59db239f1864a5d4f1570c93219dbd7ac5b6db35 | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-Lymphatic_endothelial_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 188 | 134 | 6 | a6ed43fdd42d681c9fbb2fb368947ab7e41d8d7c | |
| ToppCell | droplet-Lung-nan-18m-Endothelial-endothelial_cell_of_lymphatic_vessel|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 188 | 134 | 6 | 54550313db78b3b5b572fa1e67092c8f6f33aab5 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-oligodendrocyte_precursor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 188 | 134 | 6 | 006db2c2c44971ca9241c582bc89f258c785f5ed | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus_-18m-Macroglial-Oligodendrocyte_progenitor_cell|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.26e-05 | 188 | 134 | 6 | d0e6fb4a3b3d79d3512b5500062ea285495ae526 | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-Basal|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 189 | 134 | 6 | 783c1db856f2defe6f3b8748dd0bc29a8102f6d1 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.33e-05 | 189 | 134 | 6 | a153b83314cf52808f685296cff8c95af3f4983d | |
| ToppCell | facs-Lung-EPCAM-18m-Epithelial-respiratory_basal_cell|Lung / Lung_Trachea - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.33e-05 | 189 | 134 | 6 | 88b72fafbe58463543e0818f27f3dd9e5b4d34d2 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.33e-05 | 189 | 134 | 6 | c734e5693808a0333139e87bd5be2597a9252afe | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-05 | 190 | 134 | 6 | 47e07ea22733306d8885ee9e5f0b033e2f5e2afb | |
| ToppCell | facs-Lung-18m-Epithelial-airway_epithelial-respiratory_basal_cell-basal_epithelial_cell_of_bronchioalveolar_tree|18m / method, tissue, age, lineage, sublineage, cell ontologies, cell type and subtype | 2.40e-05 | 190 | 134 | 6 | 261b8afddfdcba4f70b50df126cef7ad00a0aae0 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 190 | 134 | 6 | 2e592323085ba9c019d678ac2a784462ab470ed9 | |
| ToppCell | E17.5-Epithelial-epithelial_progenitor_cell-epithelial_progenitor_cell|E17.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.40e-05 | 190 | 134 | 6 | 8e9ba1f1af520564a1a7dfa9ef74ef5f0d0bf0d5 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-high_collagen-matrisome_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.40e-05 | 190 | 134 | 6 | 445952b70abffadb6ccc1ed4bbf61a88b06b73b3 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-05 | 190 | 134 | 6 | 841cd55861b43578d704418b9bc0af2e8b88323a | |
| ToppCell | LPS_only-Stromal_mesenchymal-Matrix_Fibroblast-Diff_MatrixFB|LPS_only / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.40e-05 | 190 | 134 | 6 | d60395739458d7f47a3350ade751fe3819500320 | |
| ToppCell | droplet-Mammary_Gland-nan-18m-Epithelial-luminal_epithelial_cell_of_mammary_gland|Mammary_Gland / Skin_Bladder_Kidney_Mammary_Gland - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.47e-05 | 191 | 134 | 6 | c21e7904e06a5c90176f935f6822dbb5a1aa6755 | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast-Activated_MatrixFB|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.47e-05 | 191 | 134 | 6 | b13229bb7f3713a392271aaf5dbae3edd1b9fe5a | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast-|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 191 | 134 | 6 | c54c420a94dc749ebc67fc64c5614663f4b9798d | |
| ToppCell | E15.5-Epithelial-alveolar_epithelial_cell-type_I_pneumocyte|E15.5 / developmental_time, Lineage, Cell group, Cell type, Cell type_cellcyc-phase | 2.47e-05 | 191 | 134 | 6 | 402c341b00f98e8215458766b3c219fff8dcb447 | |
| ToppCell | 10x_3'_v3-lymph_node_(10x_3'_v3)-lymphocytic-T_lymphocytic-CD4-positive,_alpha-beta_memory_T_cell|lymph_node_(10x_3'_v3) / Per Platform+tissue_group, by lineage_subgroup, cell_group, cell_type | 2.47e-05 | 191 | 134 | 6 | e0e87cba486608e569f257e95cde2ca8472fc3dd | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 191 | 134 | 6 | 806b94f567ea09a9f443cd4091e70cdb1253ac08 | |
| ToppCell | renal_papilla_nuclei-Adult_normal_reference-Mesenchymal-Fibroblast-Collagen-low_Matrisome-low_fibroblast|Adult_normal_reference / Celltypes from Cells and Nuclei per compartment and clinical group | 2.47e-05 | 191 | 134 | 6 | cb0aee740b08f7d5fdd2717ecf7429043b277ae7 | |
| ToppCell | RV-01._Fibroblast_I|World / Chamber and Cluster_Paper | 2.47e-05 | 191 | 134 | 6 | 70c067c54084bfb02c29bab085f4defd477194fb | |
| ToppCell | LPS-IL1RA+antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-IL1RA+antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-05 | 192 | 134 | 6 | 6f4ef24dab544681304b7f8a9dc073e7edaa4cf5 | |
| ToppCell | facs-Brain_Non-Myeloid-Cortex_-18m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 192 | 134 | 6 | d2161842a38146261847fc9061ba9322e0f087e0 | |
| ToppCell | Severe-Lymphoid-Plasma|Severe / Condition, Lineage, Cell class and cell subclass | 2.55e-05 | 192 | 134 | 6 | 8d26584c7897a2c77df9efe787e7c04d1e883df9 | |
| ToppCell | facs-Brain_Non-Myeloid-Hippocampus-3m-Macroglial-astrocyte|Brain_Non-Myeloid / Brain_Non-Myeloid_Brain_Myeloid - method, tissue, subtissue, age, lineage, cell ontology and free annotation | 2.55e-05 | 192 | 134 | 6 | 261211a86e6f63b09c2ddce1d2d9257d311f1770 | |
| ToppCell | LPS-antiTNF-Stromal_mesenchymal-Matrix_Fibroblast|LPS-antiTNF / V2 postpublication: Rhesus Genome Updated; Treatment groups by lineage, cell_type_level1, cell_type_level2 | 2.55e-05 | 192 | 134 | 6 | dcd924d6eb67d33ee9f5d3e8ab6e1d4283d6b708 | |
| ToppCell | Severe-Lymphoid-Plasma-|Severe / Condition, Lineage, Cell class and cell subclass | 2.55e-05 | 192 | 134 | 6 | 3a900d872da80b47104245440eb09b8c80b0b2b0 | |
| ToppCell | 5'-GW_trimst-2-LargeIntestine-Mesenchymal-fibroblastic-Stromal_3_(KCNN3+)|GW_trimst-2 / Celltypes from developing, pediatric, Crohn's, & adult GI tract | 2.55e-05 | 192 | 134 | 6 | 20ede290e01ad574afd122d72b59dbc52c595fad | |
| Computational | Genes in the cancer module 286 | 1.57e-07 | 37 | 73 | 6 | MODULE_286 | |
| Computational | Oxidoreductases. | 1.31e-05 | 22 | 73 | 4 | MODULE_373 | |
| Computational | Genes upregulated in subsets of cells of a given type within various tumors | 3.56e-04 | 50 | 73 | 4 | GAVISH_3CA_METAPROGRAM_B_CELLS_METABOLISM_MYC | |
| Computational | Neighborhood of ITGAL | 5.14e-04 | 55 | 73 | 4 | GNF2_ITGAL | |
| Computational | Lung genes. | 6.60e-04 | 434 | 73 | 10 | MODULE_5 | |
| Computational | Neighborhood of ZAP70 | 6.98e-04 | 26 | 73 | 3 | GNF2_ZAP70 | |
| Computational | Neighborhood of CASP8 | 7.82e-04 | 27 | 73 | 3 | GNF2_CASP8 | |
| Computational | Neighborhood of SNRK | 8.71e-04 | 28 | 73 | 3 | GNF2_SNRK | |
| Drug | gossylic iminolactone | 1.26e-10 | 7 | 132 | 5 | CID005479302 | |
| Drug | spirobishexahydropyrimidine | 5.37e-09 | 5 | 132 | 4 | CID000100750 | |
| Drug | AC1O5TJF | 5.37e-09 | 5 | 132 | 4 | CID006440410 | |
| Drug | 1,4-diethoxybutane | 5.37e-09 | 5 | 132 | 4 | CID000232578 | |
| Drug | S-lac-NAD | 5.37e-09 | 5 | 132 | 4 | CID000194292 | |
| Drug | sorbarin | 5.37e-09 | 5 | 132 | 4 | CID009824100 | |
| Drug | AC1O5ZB9 | 5.37e-09 | 5 | 132 | 4 | CID006443605 | |
| Drug | AC1L49DG | 5.37e-09 | 5 | 132 | 4 | CID000152931 | |
| Drug | N-trifluoroacetyl-glycine | 5.37e-09 | 5 | 132 | 4 | CID000136227 | |
| Drug | acetylphosphonic acid | 5.37e-09 | 5 | 132 | 4 | CID000081311 | |
| Drug | NSC-60195 | 5.37e-09 | 5 | 132 | 4 | CID000020481 | |
| Drug | ethyl gossypol | 5.37e-09 | 5 | 132 | 4 | CID000374353 | |
| Drug | oxyayanin A | 5.37e-09 | 5 | 132 | 4 | CID005281676 | |
| Drug | B-HAD | 5.37e-09 | 5 | 132 | 4 | CID000131338 | |
| Drug | SQ 31,486 | 5.37e-09 | 5 | 132 | 4 | CID000130015 | |
| Drug | BMS-188107 | 5.37e-09 | 5 | 132 | 4 | CID000192297 | |
| Drug | dhmal | 1.44e-08 | 29 | 132 | 6 | CID000151725 | |
| Drug | BL-443 | 1.60e-08 | 6 | 132 | 4 | CID000054436 | |
| Drug | dansyl-L-lysine | 1.60e-08 | 6 | 132 | 4 | CID000598797 | |
| Drug | I 65 | 1.60e-08 | 6 | 132 | 4 | CID000149068 | |
| Drug | D 701 | 1.60e-08 | 6 | 132 | 4 | CID003051460 | |
| Drug | 2,3-dihydroxy-1-naphthoic acid | 1.60e-08 | 6 | 132 | 4 | CID000028002 | |
| Drug | AC1L24G8 | 1.60e-08 | 6 | 132 | 4 | CID000066023 | |
| Drug | oxymethacil | 1.60e-08 | 6 | 132 | 4 | CID000096369 | |
| Drug | SQ 32,926 | 1.60e-08 | 6 | 132 | 4 | CID000131363 | |
| Drug | 4-methylpyrazole | 3.10e-08 | 84 | 132 | 8 | CID000003406 | |
| Drug | AC1O7170 | 3.73e-08 | 7 | 132 | 4 | CID006540699 | |
| Drug | BS35 | 3.73e-08 | 7 | 132 | 4 | CID000029316 | |
| Drug | BS36 | 3.73e-08 | 7 | 132 | 4 | CID000029308 | |
| Drug | pentabromoacetone | 3.73e-08 | 7 | 132 | 4 | CID000065579 | |
| Drug | methyl-4-hydroxy-3-nitrobenzimidate | 3.73e-08 | 7 | 132 | 4 | CID005492576 | |
| Drug | N-acetyl-9-O-lactylneuraminic acid | 3.73e-08 | 7 | 132 | 4 | CID000191486 | |
| Drug | sodium glycolate | 3.73e-08 | 7 | 132 | 4 | CID000517347 | |
| Drug | AC1NSM0G | 3.73e-08 | 7 | 132 | 4 | CID005365671 | |
| Drug | 4-methoxy-1-naphthaldehyde | 4.89e-08 | 18 | 132 | 5 | CID000085217 | |
| Drug | DOPEG | 5.72e-08 | 36 | 132 | 6 | CID000091528 | |
| Drug | p-(phenoxypropoxy)aniline | 7.42e-08 | 8 | 132 | 4 | CID000423258 | |
| Drug | BS37 | 7.42e-08 | 8 | 132 | 4 | CID000027925 | |
| Drug | U75412E | 7.42e-08 | 8 | 132 | 4 | CID003035460 | |
| Drug | AC1Q3O0A | 7.42e-08 | 8 | 132 | 4 | CID000060880 | |
| Drug | UR-12633 | 7.42e-08 | 8 | 132 | 4 | CID000128030 | |
| Drug | 2-methyl-2-pentenoate | 7.42e-08 | 8 | 132 | 4 | CID000018458 | |
| Drug | AC1L4GHU | 7.42e-08 | 8 | 132 | 4 | CID000156607 | |
| Drug | N-dodecyl morpholine | 7.42e-08 | 8 | 132 | 4 | CID000073764 | |
| Drug | S-(2-chloroethyl)-L-cysteine | 7.42e-08 | 8 | 132 | 4 | CID000034229 | |
| Drug | allyl alcohol | 8.85e-08 | 64 | 132 | 7 | CID000007858 | |
| Drug | Nicotinamide-Adenine-Dinucleotide | 1.11e-07 | 40 | 132 | 6 | DB01907 | |
| Drug | 2-NA | 1.33e-07 | 9 | 132 | 4 | CID000074128 | |
| Drug | benzamyl | 1.33e-07 | 9 | 132 | 4 | CID000160884 | |
| Drug | Bcdfg | 1.33e-07 | 9 | 132 | 4 | CID003036106 | |
| Drug | (3R,7R)-17-(6-hydroxy-1,5-dimethyl-hexyl)-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthrene-3,7-diol | 1.33e-07 | 9 | 132 | 4 | CID000440672 | |
| Drug | N-acetyl-ala-ala-ala-methyl ester | 1.33e-07 | 9 | 132 | 4 | CID000100120 | |
| Drug | 2-ethylhexanol | 1.48e-07 | 22 | 132 | 5 | CID000007720 | |
| Drug | 1-methyl-4-phenylpyridinium | 1.65e-07 | 144 | 132 | 9 | CID000039484 | |
| Drug | NADH | 1.65e-07 | 144 | 132 | 9 | DB00157 | |
| Drug | hydroxyisonobilin | 2.21e-07 | 10 | 132 | 4 | CID006438562 | |
| Drug | pyridinophane cryptand | 2.21e-07 | 10 | 132 | 4 | CID006454246 | |
| Drug | sodium oxamate | 2.21e-07 | 10 | 132 | 4 | CID000005242 | |
| Drug | FK3311 | 2.21e-07 | 10 | 132 | 4 | CID000164009 | |
| Drug | 2-keto-4-mercaptobutyric acid | 2.21e-07 | 10 | 132 | 4 | CID000151198 | |
| Drug | bis-NAD | 2.21e-07 | 10 | 132 | 4 | CID003081557 | |
| Drug | mivazerol | 2.21e-07 | 10 | 132 | 4 | CID000060783 | |
| Drug | phosphoenolthiopyruvate | 2.21e-07 | 10 | 132 | 4 | CID000194910 | |
| Drug | uric acid | IMPDH2 LDHAL6B MCCC2 LDHA ADAR LDHB LDHC CLCN5 NRXN2 SLC17A1 | 2.57e-07 | 199 | 132 | 10 | CID000001175 |
| Drug | mazindol | 2.94e-07 | 76 | 132 | 7 | CID000004020 | |
| Drug | hexandiol | 3.45e-07 | 11 | 132 | 4 | CID000147023 | |
| Drug | 5-ethylphenazin-5-ium | 3.45e-07 | 11 | 132 | 4 | CID000082689 | |
| Drug | hydrazinium nitrate | 3.45e-07 | 11 | 132 | 4 | CID000166817 | |
| Drug | polyvinylpyridine-N-oxide | 3.45e-07 | 11 | 132 | 4 | CID000024772 | |
| Drug | l 3000 | 4.42e-07 | 27 | 132 | 5 | CID000102475 | |
| Drug | LG61 | 5.15e-07 | 12 | 132 | 4 | CID000520177 | |
| Drug | U74500A | 5.15e-07 | 12 | 132 | 4 | CID000107964 | |
| Drug | hexa-2,4-dien-1-ol | 5.15e-07 | 12 | 132 | 4 | CID000008104 | |
| Drug | diphenaldehyde | 7.41e-07 | 13 | 132 | 4 | CID000014585 | |
| Drug | 3-mercaptolactic acid | 7.41e-07 | 13 | 132 | 4 | CID000160645 | |
| Drug | 2-oxohexanoate | 7.41e-07 | 13 | 132 | 4 | CID000159664 | |
| Drug | T 514 | 7.41e-07 | 13 | 132 | 4 | CID000114820 | |
| Drug | 2-naphthaldehyde | 7.41e-07 | 13 | 132 | 4 | CID000006201 | |
| Drug | ox-Q | 7.59e-07 | 4 | 132 | 3 | CID000448650 | |
| Drug | Apamin | 7.59e-07 | 4 | 132 | 3 | ctd:D001030 | |
| Drug | beryllium nitrate | 1.03e-06 | 14 | 132 | 4 | CID000026126 | |
| Drug | naphthalenemethanol | 1.03e-06 | 14 | 132 | 4 | CID000020908 | |
| Drug | scymnol | 1.03e-06 | 14 | 132 | 4 | CID000165531 | |
| Drug | AC1L3P2T | 1.03e-06 | 14 | 132 | 4 | CID000119585 | |
| Drug | iodoacetic acid | 1.26e-06 | 94 | 132 | 7 | CID000005239 | |
| Drug | 6-[(3R,7R)-3,7-dihydroxy-10,13-dimethyl-2,3,4,5,6,7,8,9,11,12,14,15,16,17-tetradecahydro-1H-cyclopenta[a]phenanthren-17-yl]-2-methylheptanal | 1.40e-06 | 15 | 132 | 4 | CID000440673 | |
| Drug | Ac-YVAD-Amc | 1.40e-06 | 15 | 132 | 4 | CID000004337 | |
| Drug | 2-bromohydroquinone | 1.40e-06 | 15 | 132 | 4 | CID000068502 | |
| Drug | potassium citrate | 1.86e-06 | 16 | 132 | 4 | CID000013344 | |
| Drug | 1-methoxy-5-methylphenazine | 1.86e-06 | 16 | 132 | 4 | CID000127832 | |
| Drug | tripotassium citrate monohydrate | 1.86e-06 | 16 | 132 | 4 | CID002735208 | |
| Drug | naphthaldehyde | 1.86e-06 | 16 | 132 | 4 | CID000006195 | |
| Drug | C4H3NO4 | 1.89e-06 | 5 | 132 | 3 | CID000448651 | |
| Drug | tauroursodeoxycholate | 1.93e-06 | 64 | 132 | 6 | CID000010591 | |
| Drug | Mctp | 2.28e-06 | 37 | 132 | 5 | CID000129268 | |
| Drug | Calpain Inhibitor Vi | 2.42e-06 | 17 | 132 | 4 | CID009885817 | |
| Drug | CP-320650-01 [172079-28-6]; Up 200; 10uM; PC3; HT_HG-U133A | 2.50e-06 | 199 | 132 | 9 | 3822_UP | |
| Drug | diphenyl diselenide | 2.61e-06 | 38 | 132 | 5 | CID000015460 | |
| Drug | AC1O748K | 3.01e-06 | 69 | 132 | 6 | CID006518413 | |
| Drug | acromelic acid A | 3.10e-06 | 18 | 132 | 4 | CID000108086 | |
| Disease | disease of metabolism (implicated_via_orthology) | 1.97e-06 | 21 | 129 | 4 | DOID:0014667 (implicated_via_orthology) | |
| Disease | alcohol dependence measurement | 4.31e-06 | 55 | 129 | 5 | EFO_0007835 | |
| Disease | azoospermia (implicated_via_orthology) | 5.66e-06 | 27 | 129 | 4 | DOID:14227 (implicated_via_orthology) | |
| Disease | alcohol use disorder measurement, alcohol dependence | 1.54e-04 | 24 | 129 | 3 | EFO_0009458, MONDO_0007079 | |
| Disease | medial orbital frontal cortex volume measurement | 1.75e-04 | 25 | 129 | 3 | EFO_0010315 | |
| Disease | Alcohol dependence | 1.88e-04 | 5 | 129 | 2 | cv:C0001973 | |
| Disease | ALCOHOL DEPENDENCE | 1.88e-04 | 5 | 129 | 2 | 103780 | |
| Disease | coenzyme Q10 deficiency disease (implicated_via_orthology) | 3.93e-04 | 7 | 129 | 2 | DOID:0050730 (implicated_via_orthology) | |
| Disease | alcohol use disorder measurement, longitudinal alcohol consumption measurement | 5.69e-04 | 37 | 129 | 3 | EFO_0007645, EFO_0009458 | |
| Disease | human papilloma virus infection, oral cavity cancer | 8.27e-04 | 42 | 129 | 3 | EFO_0001668, EFO_0005570 | |
| Disease | Alcohol Use Disorder | 9.48e-04 | 44 | 129 | 3 | C0001956 | |
| Disease | Alcoholic Intoxication, Chronic | 1.19e-03 | 268 | 129 | 6 | C0001973 | |
| Disease | interleukin 6 receptor subunit alpha measurement | 1.43e-03 | 13 | 129 | 2 | EFO_0008187 | |
| Disease | 3-carboxy-4-methyl-5-propyl-2-furanpropanoate CMPF measurement | 1.43e-03 | 13 | 129 | 2 | EFO_0021053 | |
| Disease | gout | 1.74e-03 | 196 | 129 | 5 | EFO_0004274 | |
| Disease | Schizophrenia | ACSL6 MAOB CASP4 RGS12 CCND2 NRXN3 NRXN1 NRXN2 PTPRZ1 GPR153 KCNN3 | 1.75e-03 | 883 | 129 | 11 | C0036341 |
| Disease | birth weight | 1.91e-03 | 399 | 129 | 7 | EFO_0004344 | |
| Disease | amyotrophic lateral sclerosis, age at onset | 1.92e-03 | 15 | 129 | 2 | EFO_0004847, MONDO_0004976 | |
| Disease | hemorheological measurement | 1.92e-03 | 15 | 129 | 2 | EFO_0803374 | |
| Disease | alcohol use disorder (is_implicated_in) | 2.19e-03 | 16 | 129 | 2 | DOID:1574 (is_implicated_in) | |
| Disease | triacylglycerol 50:5 measurement | 2.19e-03 | 16 | 129 | 2 | EFO_0010412 | |
| Disease | CCL2 measurement | 2.31e-03 | 126 | 129 | 4 | EFO_0004749 | |
| Disease | alcohol use disorder measurement | 2.55e-03 | 214 | 129 | 5 | EFO_0009458 | |
| Disease | bitter alcoholic beverage consumption measurement | 2.81e-03 | 133 | 129 | 4 | EFO_0010092 | |
| Disease | Alcohol abuse | 3.19e-03 | 67 | 129 | 3 | C0085762 | |
| Disease | sex interaction measurement, cerebral amyloid angiopathy | 3.77e-03 | 21 | 129 | 2 | EFO_0006790, EFO_0008343 | |
| Disease | lifestyle measurement | 3.80e-03 | 235 | 129 | 5 | EFO_0010724 |
| Peptide | Gene | Start | Entry |
|---|---|---|---|
| GIGVVECMAAGTIIL | 401 | Q2TAA5 | |
| TIHGMAGCGKSVLAA | 151 | O14727 | |
| SARAVTGMAGVGCLF | 226 | P51689 | |
| MGAAISQGALIAIVC | 1 | Q6UWT2 | |
| ASVIMRGSSGGGVSC | 206 | O00478 | |
| ASVIMRGSSGEGVSC | 206 | O00481 | |
| CAVFGLGGVGLSAVM | 201 | P08319 | |
| CAVFGLGGVGLSVVM | 196 | P28332 | |
| VLMSHGILEGICGTV | 206 | P49662 | |
| MAGLNCGVSIALLGV | 1 | Q9H5V8 | |
| CAVFGLGGVGLSAVM | 196 | P00325 | |
| CAVFGLGGVGLSVVM | 196 | P00326 | |
| GIVSCSGVLEVGTMT | 361 | Q96L96 | |
| TMIVGQVGCGKSSLL | 701 | O60706 | |
| VLVKDGVGVGVSCMA | 171 | O95376 | |
| VKTSMICAGGDGVIS | 196 | P08217 | |
| ALGVMLASAITIGCV | 481 | O43246 | |
| GIVFILSGLCSMTGC | 121 | P78369 | |
| VVLDVGSGTGILCMF | 91 | Q99873 | |
| GFLVCMGVILAIGNA | 301 | P98198 | |
| GGVCFMSAGISSLIS | 121 | P56880 | |
| HCSAGIGRTGVLVTM | 841 | P26045 | |
| HCSAGIGRTGVLITM | 851 | P29074 | |
| GGGLSGTCVVFVQVM | 326 | Q9Y5E7 | |
| NKITVVGVGAVGMAC | 21 | P00338 | |
| VGVGAVGMACAISIL | 26 | P00338 | |
| MIATGSVGAAICGLQ | 201 | P30279 | |
| MGGAATICSAIVSAA | 306 | P28838 | |
| MSNKCDVVVVGGGIS | 1 | P27338 | |
| GTGAILMRGAGCTIN | 116 | Q96H96 | |
| GATQMALGCLIVAVS | 36 | O60320 | |
| TGMVVGIVAAAALCI | 396 | P58400 | |
| GTGLTECILSGIMSV | 11 | P50395 | |
| VAAQACAVGAIMLGA | 66 | Q9P298 | |
| VVALSVMGHTGGLGC | 211 | A6NDP7 | |
| LVTNTLGCGALMAAG | 26 | Q567V2 | |
| TGIGRVSGVECMIIA | 121 | Q9HCC0 | |
| IAQIAVVMGSCTAGG | 206 | Q9HCC0 | |
| MCIVTVLSHGLRSGG | 2541 | Q14643 | |
| LAGCALMALSVSGIG | 301 | O95528 | |
| LLTGIMGAGCTALVV | 376 | Q9H2S1 | |
| MGAGCTALVVAVVAR | 381 | Q9H2S1 | |
| CLVIGVGTMSGVRQL | 176 | P04035 | |
| GGRGVTLMVACVSPS | 326 | Q96FN5 | |
| LRVGMGSGSICITQE | 321 | P12268 | |
| VCLLTGIMGAGCTAL | 346 | Q92952 | |
| GIMGAGCTALVVAVV | 351 | Q92952 | |
| MADVSLRGITGSCGL | 436 | O95822 | |
| TGSVITTQGVCLGMR | 186 | Q96HB5 | |
| RLLGMSAGVCGITAL | 291 | Q8IWD5 | |
| LTGIMGAGCTALVVA | 526 | Q9UGI6 | |
| KVSIIGTGSVGMACA | 71 | Q9BYZ2 | |
| GTGSVGMACAISILL | 76 | Q9BYZ2 | |
| MIVVSALGVGGGCFI | 196 | Q8NHC7 | |
| TGVCAIIGGMFTVAG | 346 | Q9Y282 | |
| FLLLVGGSVAMGVIC | 176 | Q6NV75 | |
| GGSVAMGVICTAIAL | 181 | Q6NV75 | |
| AMSSLGVLLGATCAG | 871 | O60462 | |
| TGMVVGIVAAAALCI | 1636 | Q9P2S2 | |
| CKITIVGTGAVGMAC | 21 | P07864 | |
| VGTGAVGMACAISIL | 26 | P07864 | |
| TGMVVGIVAAAALCI | 1401 | Q9ULB1 | |
| GGVTAGTFCALTTLM | 2226 | P23471 | |
| VVGDGAVGKTCLLMS | 26 | Q9H4E5 | |
| AGVGRTGCFIVIDAM | 1591 | Q13332 | |
| GTMTLELGGTVNITC | 581 | Q9BZF1 | |
| SIGTAMLGAGLCVGF | 66 | Q9NRN9 | |
| GIASSIVMLIICGGL | 386 | Q8TED4 | |
| MTVGGKIVGSLCAIA | 431 | P17658 | |
| IFGTGIIGNLAVMCI | 271 | O15354 | |
| LGAGTLGCNVARTLM | 361 | O95352 | |
| TGNMVIVVIGGLAEC | 176 | Q6E213 | |
| MGVVVSLGTGNRCVK | 881 | P55265 | |
| VGGCVVGIAMARFAD | 326 | Q96SL1 | |
| VGFMGCSVTSKGVIH | 521 | Q9UF56 | |
| GAAACLGGVTRMTVS | 576 | P51795 | |
| VGEKVTVSCSGGMSL | 651 | P10643 | |
| LCTTRVLGMELAGGV | 316 | Q96D53 | |
| ASVIMRGGSGEGVSC | 206 | P78410 | |
| TLVVAGMVGSILCGL | 376 | Q9Y5Y0 | |
| VVGVGQVGMACAISI | 26 | P07195 | |
| LGCGLAVAVTMGRTV | 11 | Q3LI62 | |
| MASSAAGCVVIVGSG | 1 | Q9Y2S2 | |
| GTGLTECILSGIMSV | 11 | P31150 | |
| VAGTVVMVTGVLGCC | 66 | P48509 | |
| GIKQAGFTTGMCVII | 141 | Q8NBW4 | |
| SGIMFIVSGLCAIAG | 121 | P56856 | |
| MVAVTGGVGVAAALC | 446 | Q6NUT3 | |
| GTGVASMITCSIEGS | 1336 | Q9C0B2 | |
| NTGCILGVGLVLSLM | 1136 | Q5VW36 | |
| GGSVNLTCVAVGAPM | 246 | P10586 | |
| GVGRTGCFIVIDAML | 1551 | P10586 | |
| ICGVKGGETVMVNAA | 136 | Q14914 | |
| GVGRTGCFIVIDAML | 1556 | P23468 | |
| AMDGGGLSARCTVLI | 321 | Q9Y5E1 | |
| CGSFGIGLTMAVLHV | 146 | Q8NHC4 | |
| FLGICVVTVVGNLGM | 31 | P0DMU2 | |
| TVCSGVTGAMNLARG | 421 | Q96Q06 | |
| MGAGVVLGSIAIITA | 311 | Q96KT7 | |
| LGTCSGMARVGALIT | 461 | Q8N4V2 | |
| AMCGGELSAVAGVVL | 626 | Q9BYH1 | |
| IGVCVRVGMALGAAD | 346 | Q86VL8 | |
| RAMGTVIIAGVVCGV | 306 | Q8N967 | |
| MQSIKCVVVGDGAVG | 1 | P84095 | |
| GVTALACGMIAVGSC | 516 | Q13200 | |
| TTGMVVGIVAAAALC | 561 | Q9HDB5 | |
| CSTLTGMIGGLIAST | 401 | Q14916 | |
| TRGCVSNTGGVFLMV | 471 | O43490 | |
| VMRAACALLNSGGGV | 46 | Q7Z7L1 | |
| CMVIAGANLGRVGVI | 181 | Q8TD47 | |
| GLAISGKLCGQMATV | 221 | Q96SF2 | |
| CMVTGGANLGRIGVI | 181 | P62701 | |
| IAVAVCLLGVGTMVG | 166 | Q8IXU6 | |
| CLLGVGTMVGADILA | 171 | Q8IXU6 | |
| SVMLGVGSRSVAGVC | 126 | Q96DW6 | |
| VFLRTMVGCGVSGHS | 141 | Q8N434 | |
| MVGCGVSGHSQGLII | 146 | Q8N434 | |
| QASLGGCVRMIVTGA | 421 | Q9UKU0 | |
| VVSRIMGRGGCNITA | 1706 | Q8IWZ3 | |
| GTLILVMFGCGSVAQ | 31 | Q92482 | |
| IGMVAGAVTGIVAGA | 231 | Q9H6B4 | |
| ILAVCLGGMIGISAS | 251 | Q6UXD7 | |
| MGAGVVLGSIAIITA | 311 | P0C7Q5 | |
| LASMSLACIGIGGCT | 111 | Q5HYL7 | |
| MGTISLCIGVCAFEG | 1 | Q5SXM1 | |
| GMFSVSLGQTILCIG | 386 | Q8IU68 | |
| KCSGVLHMVIAEGVG | 86 | O14924 | |
| SVGIFGVLCLMIGET | 161 | P50443 | |
| IVGAGMTGSLCAALL | 6 | Q5VYX0 | |
| VGGVGSVTAEMLTRC | 81 | Q9GZZ9 | |
| TAILGGAMSVVSACV | 286 | Q9H1K6 | |
| SMTGVSFGCVASVLG | 171 | Q969M3 | |
| VVGLGTDGSAMLSCR | 691 | O60290 | |
| TTVKIVSLGGGCNMI | 606 | Q9H869 | |
| IGHMGICTSTGVIRD | 71 | Q9H0R3 | |
| VLGVIIAATCMGLTS | 401 | Q6PML9 | |
| MAGSVGLALCGQTLV | 1 | P57081 | |
| LGAAGTGMVVATVAS | 706 | P0DP72 | |
| KTMVVSGAAGACGSV | 156 | Q8N8N7 | |
| MVGRNSAIAAGVCGA | 1 | Q15388 | |
| AVAGMVLTVIGISLC | 111 | Q8WY98 | |
| GTIVMVTGFLGCLGA | 61 | O75954 | |
| VGTLSGMVCPLIVGA | 456 | Q8NDX2 | |
| GGTMLITSGCAVAVN | 126 | Q9BRI3 | |
| GMLVGALCALAGVLT | 516 | Q14003 | |
| VLMCIGVTSGVGRLL | 331 | Q8TF71 | |
| GCSEQITKGLVMVAG | 86 | P53667 |